Wolff Wiese Magana’s Biogen BIIB Stock Holding History

Wolff Wiese Magana’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08K	Hold	5	–	–	﹤0.01%	912
2026 Q1	$917	Hold	5	–	–	﹤0.01%	875
2025 Q4	$880	Hold	5	–	–	﹤0.01%	847
2025 Q3	$701	Hold	5	–	–	﹤0.01%	874
2025 Q2	$628	Sell	5 -11	-69%	-$1.37K	﹤0.01%	886
2025 Q1	$2.19K	Hold	16	–	–	﹤0.01%	716
2024 Q4	$2.45K	Sell	16 -29	-64%	-$4.89K	﹤0.01%	675
2024 Q3	$8.72K	Buy	45 +43	+2,150%	+$9K	0.01%	473
2024 Q2	$464	Hold	2	–	–	﹤0.01%	711
2024 Q1	$432	Hold	2	–	–	﹤0.01%	647
2023 Q4	$518	Hold	2	–	–	﹤0.01%	620
2023 Q3	$515	Hold	2	–	–	﹤0.01%	693
2023 Q2	$570	Hold	2	–	–	﹤0.01%	676
2023 Q1	$557	Hold	2	–	–	﹤0.01%	634
2022 Q4	$554	Sell	2 -349	-99%	-$98.6K	﹤0.01%	636
2022 Q3	$94K	Sell	351 -35	-9%	-$7.43K	0.08%	167
2022 Q2	$79K	Sell	386 -78	-17%	-$15.9K	0.06%	200
2022 Q1	$98K	Hold	464	–	–	0.07%	189
2021 Q4	$111K	Sell	464 -5	-1%	-$1.29K	0.07%	193
2021 Q3	$132K	Hold	469	–	–	0.09%	165
2021 Q2	$163K	Sell	469 -17	-3%	-$5.15K	0.12%	142
2021 Q1	$136K	Hold	486	–	–	0.11%	156
2020 Q4	$119K	Buy	+486	New	+$125K	0.1%	160

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wolff Wiese Magana's BIIB Position: Q2 2026 in Review

Wolff Wiese Magana held its Biogen (BIIB) position steady in Q2 2026 at 5 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #912.

Wolff Wiese Magana first reported a position in BIIB in Q4 2020 and has held it in 23 quarters since. The position peaked at $163K in Q2 2021. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Wolff Wiese Magana held 5 shares of Biogen worth $1.08K as of Q2 2026.
Wolff Wiese Magana left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #912 holding.
Wolff Wiese Magana first reported a position in Biogen in Q4 2020 and has held it in 23 quarters since.
Wolff Wiese Magana's Biogen position peaked at $163K in Q2 2021.
1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.